Minneapolis
89°F
eEdition
News & Politics
Sports
Food & Culture
Business
Outdoors
Opinion
Things To Do
Obituaries
More of What Matters to Minnesota
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Minnesota State Top Stocks
Markets
Minnesota Stocks
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
United Therapeutic
(NQ:
UTHR
)
348.03
+1.16 (+0.33%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
197,995
Open
348.04
Bid (Size)
347.78 (5)
Ask (Size)
348.03 (2)
Prev. Close
346.87
Today's Range
344.15 - 349.96
52wk Range
208.62 - 353.50
Shares Outstanding
44,891,523
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Biohaven Stock Earns Relative Strength Rating Upgrade
August 21, 2024
Biohaven stock saw a positive improvement to its Relative Strength (RS) Rating on Wednesday, rising from 88 to 91.
Via
Investor's Business Daily
SpringWorks Therapeutics Stock Clears Key Benchmark, Hitting 80-Plus RS Rating
August 21, 2024
A Relative Strength Rating upgrade for SpringWorks Therapeutics shows improving technical performance.
Via
Investor's Business Daily
Performance
YTD
+53.08%
+53.08%
1 Month
+4.96%
+4.96%
3 Month
+27.54%
+27.54%
6 Month
+53.30%
+53.30%
1 Year
+50.97%
+50.97%
More News
Read More
The Analyst Verdict: United Therapeutics In The Eyes Of 8 Experts
August 20, 2024
Via
Benzinga
Soviet Code Breaker Jim Simons' Hedge Fund Renaissance Technologies — Ozempic, Wegovy Maker Novo Nordisk Along With Nvidia, Palantir Among Top Holdings
August 19, 2024
Via
Benzinga
ZIM Integrated Shipping Services Posts Upbeat Earnings, Joins fuboTV, Foghorn Therapeutics And Other Big Stocks Moving Higher On Monday
August 19, 2024
Via
Benzinga
$100 Invested In This Stock 10 Years Ago Would Be Worth $400 Today
August 05, 2024
Via
Benzinga
Navigating 9 Analyst Ratings For United Therapeutics
July 25, 2024
Via
Benzinga
Why Liquidia Stock Just Reversed Its Seven-Day Sprint And Crashed 38%
August 19, 2024
Via
Investor's Business Daily
Rivian, Chipotle Mexican And Sirius XM Are Among Top 10 Large Cap Losers Last Week (Aug 11-Aug 17): Are The Others In Your Portfolio?
August 18, 2024
Via
Benzinga
NASDAQ:UTHR is a prime example of a stock that offers more than what meets the eye in terms of fundamentals.
August 15, 2024
Via
Chartmill
3 Biotech Stocks on Track for 50% Returns (or More) by 2028
August 04, 2024
Via
InvestorPlace
UTHR Stock Earnings: United Therapeutics Misses EPS, Beats Revenue for Q2 2024
July 31, 2024
Via
InvestorPlace
If You Invested $1000 In This Stock 20 Years Ago, You Would Have $28,000 Today
July 16, 2024
Via
Benzinga
Unveiling 6 Analyst Insights On United Therapeutics
July 08, 2024
Via
Benzinga
United Therapeutics Stock Skids On Mixed Second-Quarter Results
July 31, 2024
Via
Investor's Business Daily
United Therapeutics Corporation Reports Second Quarter 2024 Financial Results
July 31, 2024
From
United Therapeutics Corporation
Via
Business Wire
The 3 Best 3D Bioprinting Stocks to Buy Now
July 26, 2024
Via
InvestorPlace
Beam Therapeutics Stock Earns RS Rating Jump To 85
July 24, 2024
Via
Investor's Business Daily
United Therapeutics Corporation to Report Second Quarter 2024 Financial Results Before the Market Opens on Wednesday, July 31, 2024
July 24, 2024
From
United Therapeutics Corporation
Via
Business Wire
Here's How Much $1000 Invested In United Therapeutics 5 Years Ago Would Be Worth Today
July 22, 2024
Via
Benzinga
Biotech Arvinas Stock Earns 82 RS Rating
July 17, 2024
Via
Investor's Business Daily
Don't overlook NASDAQ:UTHR—it's a hidden gem with strong fundamentals and an attractive price tag.
July 17, 2024
Via
Chartmill
Denali Therapeutics Stock Gets Technical Rating Upgrade
July 16, 2024
Via
Investor's Business Daily
3 Biotech Stocks to Buy Now: Q3 Edition
July 15, 2024
Via
InvestorPlace
United Therapeutics Corporation Announces Full Enrollment of the TETON 2 Study of Inhaled Treprostinil for the Treatment of Idiopathic Pulmonary Fibrosis
July 10, 2024
From
United Therapeutics Corporation
Via
Business Wire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.